(19)
(11) EP 2 968 151 A1

(12)

(43) Date of publication:
20.01.2016 Bulletin 2016/03

(21) Application number: 14713016.5

(22) Date of filing: 11.03.2014
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
A61K 9/20(2006.01)
A61K 9/50(2006.01)
A61K 31/216(2006.01)
A61K 9/16(2006.01)
A61K 9/28(2006.01)
A61K 31/09(2006.01)
A61K 9/24(2006.01)
(86) International application number:
PCT/US2014/023106
(87) International publication number:
WO 2014/159340 (02.10.2014 Gazette 2014/40)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 13.03.2013 US 201361780689 P
30.08.2013 US 201361872019 P

(71) Applicant: Tris Pharma, Inc.
Monmouth Junction, NJ 08852 (US)

(72) Inventors:
  • NELSON, Andrea
    Edison, NJ 08817 (US)
  • CHEN, Quin-zene
    Belle Mead, NJ 08502 (US)
  • METHTA, Harsh
    Monroe Township, NJ 08831 (US)
  • TU, Yu-Hsing
    West Windsor, NJ 08850 (US)

(74) Representative: Pohlman, Sandra M. 
df-mp Dörries Frank-Molnia & Pohlman Patentanwälte Rechtsanwälte PartG mbB Theatinerstrasse 16
80333 München
80333 München (DE)

   


(54) BENZONATATE MODIFIED RELEASE SOLID TABLETS AND CAPSULES